Patents by Inventor Kei Sudo

Kei Sudo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240209027
    Abstract: The present invention relates to a peptide and a composition comprising the peptide. This peptide of the present invention comprises the following amino acid sequence: MeA-MeF-S-Cha-Y-S-Y-Y-R-R-Cha-C (SEQ ID NO: 2) or an amino acid sequence having a substitution, addition, deletion, or insertion in 1 to 10 amino acid residues selected from the group consisting of amino acid residues at positions 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 in the above amino acid sequence.
    Type: Application
    Filed: March 22, 2022
    Publication date: June 27, 2024
    Inventors: Koichi Watashi, Hirofumi Ohashi, Keiichi Masuya, Masaki Ohuchi, Haruaki Kurasaki, Katsuma Matsui, Takayuki Nagasawa, Junpei Yamamoto, Kazutaka Nagatomo, Kei Sudo, Naoko Nakamura, Koji Yoshida, Yoshiaki Shimada, Tatsuya Niimi, Yoshiaki Masuda, Naoko Iwata, Nozomi Shiwa, Noriyo Nagata, Tadaki Suzuki, Hidetomo Kitamura
  • Patent number: 11535654
    Abstract: The present invention addresses the problem of providing: a fusion protein or conjugated protein having excellent cell membrane permeability, containing a partial peptide derived from human, and suitable for intracellular delivery; an intracellular delivery carrier comprising such a fusion protein or conjugated protein; a partial peptide; a cell membrane permeation enhancer comprising the partial peptide; DNA; and a vector. The fusion protein or conjugated protein has a partial peptide comprising at least seven consecutive amino acid residues of an amino acid sequence encoded by a predetermined DNA, and a ligand directly or indirectly bound to the partial peptide and having the capability of binding to cell surfaces. The ligand is preferably an antibody. The intracellular delivery carrier comprises the fusion protein or conjugated protein. The cell membrane permeation enhancer comprises the partial peptide.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: December 27, 2022
    Assignee: Keio University
    Inventors: Kei Sudo, Keisuke Niikura, Nobuhide Doi
  • Publication number: 20180237482
    Abstract: The present invention addresses the problem of providing: a fusion protein or conjugated protein having excellent cell membrane permeability, containing a partial peptide derived from human, and suitable for intracellular delivery; an intracellular delivery carrier comprising such a fusion protein or conjugated protein; a partial peptide; a cell membrane permeation enhancer comprising the partial peptide; DNA; and a vector. The fusion protein or conjugated protein has a partial peptide comprising at least seven consecutive amino acid residues of an amino acid sequence encoded by a predetermined DNA, and a ligand directly or indirectly bound to the partial peptide and having the capability of binding to cell surfaces. The ligand is preferably an antibody. The intracellular delivery carrier comprises the fusion protein or conjugated protein. The cell membrane permeation enhancer comprises the partial peptide.
    Type: Application
    Filed: June 2, 2016
    Publication date: August 23, 2018
    Inventors: Kei Sudo, Keisuke Niikura, Nobuhide Doi